TY - JOUR T1 - ThinkCancer! The multi-method development of a complex behaviour change intervention to improve the early diagnosis of cancer in primary care JF - medRxiv DO - 10.1101/2020.11.20.20235614 SP - 2020.11.20.20235614 AU - A Surgey AU - S Disbeschl AU - R Lewis AU - J Hiscock AU - S Nafees AU - R J Law AU - J L Roberts AU - A Hendry AU - Z Hoare AU - N Goulden AU - M A Stanciu AU - A Carson-Stevens AU - S Smits AU - K Brain AU - R T Edwards AU - N Williams AU - R D Neal AU - C Wilkinson Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/23/2020.11.20.20235614.abstract N2 - Background Relatively poor UK cancer outcomes are blamed upon late diagnosis. Despite most cancer patients presenting to their GP with symptoms, diagnostic delay remains a common theme, with many clinical and non-clinical factors responsible. Early diagnosis is key to improving outcomes and survival. This paper reports the multi-method process to design a complex intervention to improve the timely diagnosis of symptomatic cancer.Methods A review of reviews, survey, discrete choice experiment, qualitative interviews and focus groups, all informed a realist evidence synthesis. This in turn informed the design of a complex intervention, guided by the Behaviour Change Wheel framework using a multi-step process.Results Key themes from the realist evidence synthesis included effective safety netting at practitioner and practice system level, increased vigilance and lowering referral thresholds. Qualitative findings explored the tensions, barriers and facilitators affecting suspected cancer referral. The Think Cancer! intervention is an educational and quality improvement workshop directed at the whole primary care team. Bespoke cancer safety netting plans and appointment of cancer champions are key components.Conclusions Think Cancer! is a novel primary care early cancer diagnosis intervention, requiring evaluation through a cluster randomised control trial.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialR48C11Funding StatementThe WICKED research programme is entirely funded by Cancer Research Wales. RDN is an associate director of the CanTest Collaborative funded by Cancer Research UK (C8640/A23385).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval granted by Bangor University (School of Healthcare Science) and NHS R&D permissions granted in al Welsh Health Boards (Integrated Research Application System reference number: 213034).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSupplementary files referred to in this manuscript are attached. ER -